Central Hyperthermia Treated with Cabergoline: A Case Report
Abstract
A 36-year-old male with acute traumatic spinal cord injury (ATSCI) was diagnosed with central hyperthermia after a worksite injury.After the management of infection with antibiotics guided by culture & sensitivity results and presence of persistent fever (> 40°C), tablet Cabergoline was prescribed (0.5mg every week) in Hospital Day 23. Improvement in the temperature chart was noticed from Hospital Day 29 and persisted. Tablet Cabergoline may have a role in the management of Central hyperthermia.
Full text article
Generated from XML file
Authors
Taha, A. M. ., Al-Yousef, E. K. ., & Jawhar, D. S. . (2022). Central Hyperthermia Treated with Cabergoline: A Case Report. Journal of Current Medical Research and Opinion, 5(11), 1486–1489. https://doi.org/10.52845/CMRO/2022/5-11-4
Copyright and license info is not available